Glimesoft MV 2mg/500mg/0.3mg Tablet
Marketer
Pillix Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Glimesoft MV 2mg/500mg/0.3mg Tablet
Diabetacomb MV 2mg/500mg/0.3mg tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Diabetacomb MV should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption elevates hypoglycemia risk and should be avoided. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended under your doctor's guidance.
Primary Ingredients of Glimesoft MV 2mg/500mg/0.3mg Tablet
No text was provided. Please provide the text you wish me to rephrase.
Uses of Glimesoft MV 2mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Glimesoft MV 2mg/500mg/0.3mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the Glimesoft MV 2mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or fracturing it. Take it on an empty stomach.
Common Side effects of Glimesoft MV 2mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Glimesoft MV 2mg/500mg/0.3mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Glimesoft MV 2mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume the tablet on an empty stomach.
How Glimesoft MV 2mg/500mg/0.3mg Tablet works:
Each Glimesoft MV 2mg/500mg/0.3mg tablet contains a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimesoft MV 2mg/500mg/0.3mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glimesoft MV 2mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Using Glimesoft MV 2mg/500mg/0.3mg tablets while breastfeeding is likely inadvisable. Preliminary evidence indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Glimesoft MV 2mg/500mg/0.3mg tablets in patients with kidney disease carries a high risk and is best avoided. Patients with severe kidney impairment should definitely not use this medication. Medical advice is recommended before taking this drug.
LiverCAUTION
Patients with liver impairment should use Glimesoft MV 2mg/500mg/0.3mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. In those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in cases of severe hepatic dysfunction.
What if you forget to take Glimesoft MV 2mg/500mg/0.3mg Tablet :
Should you forget to take a Glimesoft MV 2mg/500mg/0.3mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimesoft MV 2mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently